{"hands_on_practices": [{"introduction": "The first step in characterizing a new enzyme inhibitor drug is to determine its mechanism of action. By observing how the drug alters the enzyme's key kinetic parameters—the Michaelis constant ($K_M$) and the maximum velocity ($V_{max}$)—we can classify its type of inhibition. This fundamental exercise tests your understanding of the distinct kinetic signatures of competitive and non-competitive inhibitors, a crucial skill for interpreting experimental data in drug discovery [@problem_id:2044457].", "problem": "A biochemist is tasked with characterizing two new drug candidates, labeled Drug A and Drug B, which are known to inhibit a specific enzyme that follows Michaelis-Menten kinetics. It has been established that one drug is a pure competitive inhibitor and the other is a pure non-competitive inhibitor, but their specific identities are unknown. To identify them, the biochemist runs a series of kinetic assays. The initial reaction velocity ($v_0$) is measured under three conditions: (1) with the enzyme and substrate alone (uninhibited), (2) with the enzyme, substrate, and a fixed concentration of Drug A, and (3) with the enzyme, substrate, and the same fixed concentration of Drug B. For each condition, the substrate concentration, [S], is varied over a wide range.\n\nThe Michaelis constant and maximum velocity for the uninhibited enzyme are denoted as $K_M$ and $V_{max}$, respectively. The apparent Michaelis constant and maximum velocity in the presence of an inhibitor are denoted as $K_{M,app}$ and $V_{max,app}$.\n\nWhich of the following sets of observations would correctly identify Drug A as the competitive inhibitor and Drug B as the non-competitive inhibitor?\n\nA. Drug A: $K_{M,app} > K_M$ and $V_{max,app} < V_{max}$; Drug B: $K_{M,app} = K_M$ and $V_{max,app} < V_{max}$.\n\nB. Drug A: $K_{M,app} = K_M$ and $V_{max,app} < V_{max}$; Drug B: $K_{M,app} > K_M$ and $V_{max,app} = V_{max}$.\n\nC. Drug A: $K_{M,app} > K_M$ and $V_{max,app} = V_{max}$; Drug B: $K_{M,app} > K_M$ and $V_{max,app} < V_{max}$.\n\nD. Drug A: $K_{M,app} > K_M$ and $V_{max,app} = V_{max}$; Drug B: $K_{M,app} = K_M$ and $V_{max,app} < V_{max}$.\n\nE. Drug A: $K_{M,app} = K_M$ and $V_{max,app} = V_{max}$; Drug B: $K_{M,app} > K_M$ and $V_{max,app} < V_{max}$.", "solution": "The initial velocity for a simple Michaelis-Menten enzyme without inhibitor is given by the Michaelis-Menten equation:\n$$\nv_{0}=\\frac{V_{max}[S]}{K_{M}+[S]}.\n$$\nA competitive inhibitor binds to the free enzyme and competes with substrate binding. In the presence of a competitive inhibitor at concentration $[I]$ with inhibition constant $K_{i}$, the velocity becomes\n$$\nv_{0}=\\frac{V_{max}[S]}{\\alpha K_{M}+[S]},\\quad \\alpha=1+\\frac{[I]}{K_{i}}.\n$$\nBy comparing to the uninhibited form, the apparent parameters are\n$$\nK_{M,app}=\\alpha K_{M}>K_{M},\\qquad V_{max,app}=V_{max}.\n$$\nThus a pure competitive inhibitor increases $K_{M}$ while leaving $V_{max}$ unchanged.\n\nA pure non-competitive inhibitor (in the strict sense, equal affinity for $E$ and $ES$) reduces the effective catalytic capacity without changing substrate affinity. In the presence of such an inhibitor with parameter $\\alpha'=1+[I]/K_{i}'$, the rate law can be written as\n$$\nv_{0}=\\frac{V_{max}/\\alpha'\\,[S]}{K_{M}+[S]},\n$$\nso the apparent parameters are\n$$\nK_{M,app}=K_{M},\\qquad V_{max,app}=\\frac{V_{max}}{\\alpha'}<V_{max}.\n$$\nThus a pure non-competitive inhibitor leaves $K_{M}$ unchanged and decreases $V_{max}$.\n\nTo identify Drug A as competitive and Drug B as non-competitive, the observations must show for Drug A: $K_{M,app}>K_{M}$ and $V_{max,app}=V_{max}$; and for Drug B: $K_{M,app}=K_{M}$ and $V_{max,app}<V_{max}$. Among the options, this pattern is exactly described by option D.", "answer": "$$\\boxed{D}$$", "id": "2044457"}, {"introduction": "Once an inhibitor's mechanism has been identified, the next critical step is to quantify its potency. The inhibitor constant, $K_I$, provides a direct measure of the inhibitor's binding affinity to the enzyme, with lower values indicating a more potent drug. This practice problem guides you through calculating $K_I$ from experimental data for a non-competitive inhibitor, translating raw velocity measurements into a fundamental parameter for drug evaluation [@problem_id:2044474].", "problem": "A team of biochemists is developing a new drug, \"Inhibitor X,\" designed to target a specific enzyme crucial for a pathogen's survival. The enzyme follows Michaelis-Menten kinetics. In the absence of any inhibitor, the enzyme has a maximum velocity ($V_{max}$) of 200.0 µM/s and a Michaelis constant ($K_m$) of 50.0 µM.\n\nTo characterize the drug's effect, the team performs a kinetic assay. They discover that Inhibitor X acts as a classic non-competitive inhibitor. In an experiment conducted with a substrate concentration of 50.0 µM and an Inhibitor X concentration of 10.0 µM, the initial velocity ($v_0$) of the reaction is measured to be 40.0 µM/s.\n\nBased on this information, calculate the inhibitor constant ($K_I$) for Inhibitor X. Express your final answer in units of µM, rounded to three significant figures.", "solution": "For classic non-competitive inhibition, the inhibitor reduces the effective maximum velocity while leaving the Michaelis constant unchanged. The initial velocity with inhibitor is given by\n$$\nv_{0}=\\frac{V_{max}}{1+\\frac{[I]}{K_{I}}}\\cdot\\frac{[S]}{K_{m}+[S]}.\n$$\nWith $[S]=K_{m}$, this simplifies to\n$$\nv_{0}=\\frac{V_{max}}{1+\\frac{[I]}{K_{I}}}\\cdot\\frac{1}{2}=\\frac{V_{max}}{2\\left(1+\\frac{[I]}{K_{I}}\\right)}.\n$$\nSolving for $K_{I}$,\n$$\n1+\\frac{[I]}{K_{I}}=\\frac{V_{max}}{2v_{0}}\\quad\\Rightarrow\\quad \\frac{[I]}{K_{I}}=\\frac{V_{max}}{2v_{0}}-1\\quad\\Rightarrow\\quad K_{I}=\\frac{[I]}{\\frac{V_{max}}{2v_{0}}-1}.\n$$\nSubstituting the given values $V_{max}=200$, $v_{0}=40$, and $[I]=10$ (all in consistent units),\n$$\n\\frac{V_{max}}{2v_{0}}=\\frac{200}{2\\cdot 40}=\\frac{200}{80}=2.5,\n$$\nso\n$$\nK_{I}=\\frac{10}{2.5-1}=\\frac{10}{1.5}=\\frac{20}{3}\\approx 6.67.\n$$\nRounded to three significant figures, $K_{I}=6.67$ in micromolar.", "answer": "$$\\boxed{6.67}$$", "id": "2044474"}, {"introduction": "In pharmacology, a drug's potency is often reported as its $IC_{50}$ value—the concentration required to inhibit a biological process by half. However, this value is context-dependent, unlike the intrinsic inhibition constant, $K_i$. This exercise explores the critical relationship between the theoretical constant $K_i$ and the experimentally determined $IC_{50}$, demonstrating how substrate concentration directly influences the apparent potency of a competitive inhibitor [@problem_id:2044419].", "problem": "A pharmaceutical research team is characterizing a new drug candidate that functions as a competitive inhibitor for a specific enzyme. The inhibition constant, $K_i$, which represents the intrinsic dissociation constant of the enzyme-inhibitor complex, has been determined through dialysis equilibrium experiments.\n\nTo assess the drug's practical efficacy, the team conducts a kinetic assay. This assay measures the reaction velocity in the presence of varying concentrations of the inhibitor. The experiment is performed under a specific condition where the concentration of the enzyme's substrate, $[S]$, is held constant and is numerically equal to the enzyme's Michaelis constant, $K_M$. From this experiment, they determine the $IC_{50}$ value, which is defined as the inhibitor concentration required to reduce the enzyme's activity by 50%.\n\nAssuming the enzyme follows standard Michaelis-Menten kinetics, which of the following options correctly describes the quantitative relationship between the measured $IC_{50}$ and the intrinsic inhibition constant $K_i$ under these specific experimental conditions?\n\nA. $IC_{50} = \\frac{1}{2} K_i$\n\nB. $IC_{50} = K_i$\n\nC. $IC_{50} = 2 K_i$\n\nD. $IC_{50} = K_i + K_M$\n\nE. The relationship cannot be determined without knowing the total enzyme concentration.", "solution": "For a competitive inhibitor under Michaelis-Menten kinetics, the velocity in the presence of inhibitor concentration $[I]$ is\n$$\nv = \\frac{V_{\\max}[S]}{\\alpha K_{M} + [S]},\n$$\nwhere the factor $\\alpha$ accounts for competitive inhibition and is given by\n$$\n\\alpha = 1 + \\frac{[I]}{K_{i}}.\n$$\nThe uninhibited velocity at the same substrate concentration is\n$$\nv_{0} = \\frac{V_{\\max}[S]}{K_{M} + [S]}.\n$$\nBy definition, $IC_{50}$ is the inhibitor concentration that reduces the activity by a factor of $0.5$ relative to the uninhibited rate at the same $[S]$, so\n$$\n\\frac{v}{v_{0}} = \\frac{[S]/(\\alpha K_{M} + [S])}{[S]/(K_{M} + [S])} = \\frac{K_{M} + [S]}{\\alpha K_{M} + [S]} = 0.5.\n$$\nUnder the specified condition $[S] = K_{M}$, this becomes\n$$\n\\frac{K_{M} + K_{M}}{\\alpha K_{M} + K_{M}} = \\frac{2K_{M}}{(\\alpha + 1)K_{M}} = \\frac{2}{\\alpha + 1} = 0.5.\n$$\nSolving for $\\alpha$ gives\n$$\n\\alpha + 1 = 4 \\quad \\Rightarrow \\quad \\alpha = 3.\n$$\nUsing $\\alpha = 1 + \\frac{[I]}{K_{i}}$, we obtain\n$$\n1 + \\frac{IC_{50}}{K_{i}} = 3 \\quad \\Rightarrow \\quad \\frac{IC_{50}}{K_{i}} = 2 \\quad \\Rightarrow \\quad IC_{50} = 2K_{i}.\n$$\nEquivalently, this matches the Cheng-Prusoff relation $IC_{50} = K_{i}\\left(1 + \\frac{[S]}{K_{M}}\\right)$, which at $[S] = K_{M}$ yields $IC_{50} = 2K_{i}$. Therefore, the correct choice is option C.", "answer": "$$\\boxed{C}$$", "id": "2044419"}]}